Intact MET Immunoassay
BRD ID: 2246
Tier: SOP
Source: DCTD
Number of times downloaded: 860
Description
This document describes quantification of MET levels in lysates of frozen needle tumor biopsies using the Intact MET Immunoassay. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD; https://dctd.cancer.gov/). Please check the DCTD website (https://dctd.cancer.gov/drug-discovery-development/assays) for the current SOP version.
Biospecimens
TissueGeneral
Diagnoses
General
NeoplasticNot specified
Topics
Platform-specific Methodology